药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Aprobarbital
Nialamide
The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Edoxaban.
Aprobarbital
Iproniazid
The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Edoxaban.
Aprobarbital
Clorgiline
The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Edoxaban.
Aprobarbital
Pargyline
The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Edoxaban.
Aprobarbital
Rasagiline
The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Edoxaban.
Aprobarbital
Potassium
Potassium may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Bromotheophylline
Bromotheophylline may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Epitizide
Epitizide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Xipamide
Xipamide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Muzolimine
Muzolimine may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Clopamide
Clopamide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Fenquizone
Fenquizone may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Clofenamide
Clofenamide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Clorexolone
Clorexolone may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Cyclopenthiazide
Cyclopenthiazide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Mebutizide
Mebutizide may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Mefruside
Mefruside may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Meticrane
Meticrane may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Cicletanine
Cicletanine may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.
Aprobarbital
Spiradoline
Spiradoline may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy.